{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:32:08Z","timestamp":1775237528228,"version":"3.50.1"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2020,11,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> The treatment of multiple-drug-resistant tuberculosis (MDR-TB) with currently\navailable marketed drugs remains a global health concern. The cases of resistant tuberculosis\npatients are increasing day by day.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> The objective of this study is to highlight the need of developing shorter, simpler and\ntolerable drug regimens.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In the present study, we synthesized various halo-substituted 2-aryloxyacetohydrazones\nvia a series of reactions from halo-substituted phenols. All the compounds were characterized by\nusing various spectroscopic methods, such as NMR, FT-IR, UV spectroscopy, etc.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>All the synthesized hydrazones showed theoretically good interactions with enzyme enoyl\nreductase (pdb id: 4tzk). All the synthesized compounds (5a-5o) showed moderate to good activity\n(3.125-100 \u03bcg\/mL) against Mycobacteria tuberculosis, H37RV strain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> Our results would pave a new way for the development of more effective Anti-TB\nagents in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409915666191018120611","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T13:12:07Z","timestamp":1572613927000},"page":"618-628","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Synthesis and Anti-mycobacterium Study on Halo-substituted 2-aryl oxyacetohydrazones"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-7951","authenticated-orcid":true,"given":"Vijay J.","family":"Desale","sequence":"first","affiliation":[{"name":"Department of Chemistry, N.B. Mehta Science College, Bordi, Dist. Palghar-401701, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-136X","authenticated-orcid":true,"given":"Suraj N.","family":"Mali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Institute of Chemical Technology, Matunga, Mumbai 400019, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemchandra K.","family":"Chaudhari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Institute of Chemical Technology, Matunga, Mumbai 400019, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3362-8676","authenticated-orcid":true,"given":"Maya C.","family":"Mali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Institute of Chemical Technology, Matunga, Mumbai 400019, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-1319","authenticated-orcid":true,"given":"Bapu R.","family":"Thorat","sequence":"additional","affiliation":[{"name":"Faculty of P.G. and Research Centre, Department of Chemistry, Government of Maharashtra\u2019s Ismail Yusuf College, Jogeshwari, Mumbai-400060, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-5376","authenticated-orcid":true,"given":"Ramesh S.","family":"Yamgar","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Patkar-Varde College of Arts, Science and Commerce, Goregaon (W), Mumbai 400 062, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"29","volume":"1","author":"Mali S.N.","year":"2016","unstructured":"Mali S.N.; Morbale T.S.; Totally Drug-Resistant Tuberculosis (TDR-TB): An Overview. Int J Res. Methodol 2016,1(3),29-36","journal-title":"Methodol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bmcl.2016.11.071","volume":"27","author":"Angelova V.T.","year":"2017","unstructured":"Angelova V.T.; Valcheva V.; Vassilev N.G.; Buyukliev R.; Momekov G.; Dimitrov I.; Saso L.; Djukic M.; Shivachev B.; Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold. Bioorg Med Chem Lett 2017,27(2),223-227","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=3","first-page":"1177","author":"Lemke T.L.","year":"2013","unstructured":"Lemke T.L.; Williams D.A.; Roche V.F.; Zito S.W.;  Foye\u2019s principles of medicinal chemistry 2013,1177","journal-title":"Foye\u2019s principles of medicinal chemistry"},{"key":"ref=4","unstructured":"World Health Organization  (date of access: 27-06-2019)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.fitote.2009.07.010","volume":"80","author":"de Souza M.V.N.","year":"2009","unstructured":"de Souza M.V.N.; Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products. Fitoterapia 2009,80(8),453-460","journal-title":"Fitoterapia"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1874844901805010012","volume":"5","author":"Mali S.N.","year":"2018","unstructured":"Mali S.N.; Chaudhari H.K.; Computational studies on imidazo [1,2-a] pyridine-3-carboxamide analogues as antimycobacterial agents: Common pharmacophore generation, atom-based 3D-QSAR, molecular dynamics simulation, QikProp, Molecular docking and prime MMGBSA approaches. Open Pharm Sci J 2018,5,12-23","journal-title":"Open Pharm Sci J"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001363","author":"Smieja M.J.","year":"2000","unstructured":"Smieja M.J.; Marchetti C.A.; Cook D.J.; Smaill F.M.; Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000(2)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000171.pub3","author":"Akolo C.","year":"2010","unstructured":"Akolo C.; Adetifa I.; Shepperd S.; Volmink J.; Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010(1)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1084\/jem.20030846","volume":"198","author":"Schnappinger D.","year":"2003","unstructured":"Schnappinger D.; Ehrt S.; Voskuil M.I.; Liu Y.; Mangan J.A.; Monahan I.M.; Dolganov G.; Efron B.; Butcher P.D.; Nathan C.; Schoolnik G.K.; Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. J Exp Med 2003,198(5),693-704","journal-title":"J Exp Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1871526515666150724104411","volume":"15","author":"Mathew B.","year":"2015","unstructured":"Mathew B.; Suresh J.; Ahsan M.J.; Mathew G.E.; Usman D.; Subramanyan P.N.; Safna K.F.; Maddela S.; Hydrazones as a privileged structural linker in antitubercular agents: a review. Infect Disord Drug Targets 2015,15(2),76-88","journal-title":"Infect Disord Drug Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1016\/j.ejmech.2010.03.031","volume":"45","author":"Belkheiri N.","year":"2010","unstructured":"Belkheiri N.; Bouguerne B.; Bedos-Belval F.; Duran H.; Bernis C.; Salvayre R.; N\u00e8gre-Salvayre A.; Baltas M.; Synthesis and antioxidant activity evaluation of a syringic hydrazones family. Eur J Med Chem 2010,45(7),3019-3026","journal-title":"Eur J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1016\/j.bmcl.2010.08.026","volume":"20","author":"Rane R.A.","year":"2010","unstructured":"Rane R.A.; Telvekar V.N.; Synthesis and evaluation of novel chloropyrrole molecules designed by molecular hybridization of common pharmacophores as potential antimicrobial agents. Bioorg Med Chem Lett 2010,20(19),5681-5685","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0975-7406.62683","volume":"1","author":"Bawa S.","year":"2009","unstructured":"Bawa S.; Kumar S.; Drabu S.; Kumar R.; Synthesis and antimicrobial activity of 2-chloro-6- methylquinoline hydrazone derivatives. J Pharm Bioallied Sci 2009,1,27-31","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/157018012799129828","volume":"9","author":"Kaplancikli Z.A.","year":"2012","unstructured":"Kaplancikli Z.A.; Altintop M.D.; \u00d6zdemir A.; Turan-Zitounia G.; Khan S.I.; Tabanca N.; Synthesis and biological evaluation of some hydrazone derivatives as anti-inflammatory agents. Lett Drug Des Discov 2012,9,310-315","journal-title":"Lett Drug Des Discov"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.bmcl.2006.01.048","volume":"16","author":"Hu W.X.","year":"2006","unstructured":"Hu W.X.; Zhou W.; Xia C.N.; Wen X.; Synthesis and anticancer activity of thiosemicarbazones. Bioorg Med Chem Lett 2006,16(8),2213-2218","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1016\/j.bmc.2013.08.026","volume":"21","author":"Congiu C.","year":"2013","unstructured":"Congiu C.; Onnis V.; Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents. Bioorg Med Chem 2013,21(21),6592-6599","journal-title":"Bioorg Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.ejmech.2008.05.030","volume":"44","author":"Vicini P.","year":"2009","unstructured":"Vicini P.; Incerti M.; La Colla P.; Loddo R.; Anti-HIV evaluation of benzo[d]isothiazole hydrazones. Eur J Med Chem 2009,44(4),1801-1807","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.lfs.2006.01.027","volume":"79","author":"Rocha L.T.S.","year":"2006","unstructured":"Rocha L.T.S.; Costa K.A.; Oliveira A.C.P.; Nascimento E.B.; Bertollo C.M.; Ara\u00fajo F.; Teixeira L.R.; Andrade S.P.; Beraldo H.; Coelho M.M.; Antinociceptive, antiedematogenic and antiangiogenic effects of benzaldehyde semicarbazone. Life Sci 2006,79(5),499-505","journal-title":"Life Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1016\/j.bmcl.2008.09.097","volume":"18","author":"Krishnan K.","year":"2008","unstructured":"Krishnan K.; Prathiba K.; Jayaprakash V.; Basu A.; Mishra N.; Zhou B.; Hu S.; Yen Y.; Synthesis and ribonucleotide reductase inhibitory activity of thiosemicarbazones. Bioorg Med Chem Lett 2008,18(23),6248-6250","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1016\/j.bmcl.2011.04.146","volume":"21","author":"Thanigaimalai P.","year":"2011","unstructured":"Thanigaimalai P.; Lee K.C.; Sharma V.K.; Roh E.; Kim Y.; Jung S.H.; Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition. Bioorg Med Chem Lett 2011,21(12),3527-3530","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/1062936X.2019.1573377","volume":"30","author":"Mali S.N.","year":"2019","unstructured":"Mali S.N.; Chaudhari H.K.; Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR. SAR QSAR Environ Res 2019,30(3),161-180","journal-title":"SAR QSAR Environ Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1573409915666190206142756","volume":"15","author":"Mali S.N.","year":"2019","unstructured":"Mali S.N.; Sawant S.; Chaudhari H.K.; Mandewale M.C.; In silico appraisal, Synthesis, Antibacterial screening and DNA cleavage for 1,2,5-thiadiazole derivative. Curr Comput Aided Drug Des 2019,15,1","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.compbiolchem.2019.01.003","volume":"78","author":"Mishra V.R.","year":"2019","unstructured":"Mishra V.R.; Ghanavatkar C.W.; Mali S.N.; Qureshi S.I.; Chaudhari H.K.; Sekar N.; Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives. Comput Biol Chem 2019,78,330-337","journal-title":"Comput Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molstruc.2019.04.123","volume":"1192","author":"Mishra V.R.","year":"2019","unstructured":"Mishra V.R.; Ghanavatkar C.W.; Mali S.N.; Chaudhari H.K.; Sekar N.; Synthesis, bioactivities, DFT and in-silico appraisal of azo clubbed benzothiazole derivatives. J Mol Struct 2019,1192,162-171","journal-title":"J Mol Struct"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2019.1621213","volume":"38","author":"Mishra V.R.","year":"2019","unstructured":"Mishra V.R.; Ghanavatkar C.W.; Mali S.N.; Chaudhari H.K.; Sekar N.; Schiff base clubbed benzothiazole: synthesis, potent antimicrobial and MCF-7 anticancer activity, DNA cleavage and computational study. J Biomol Struct Dyn 2019,38(6),1-14","journal-title":"J Biomol Struct Dyn"},{"key":"ref=26","year":"2017","unstructured":"Glide; Schrodinger, LLC: NY,  2017"},{"key":"ref=27","year":"2017","unstructured":"LigPrep 2017","journal-title":"LigPrep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1016\/j.ejmech.2011.07.033","volume":"46","author":"Thomas K.D.","year":"2011","unstructured":"Thomas K.D.; Adhikari A.V.; Telkar S.; Chowdhury I.H.; Mahmood R.; Pal N.K.; Row G.; Sumesh E.; Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. Eur J Med Chem 2011,46(11),5283-5292","journal-title":"Eur J Med Chem"},{"key":"ref=29","year":"2017","unstructured":"Prime; Schrodinger, LLC: NY 2017"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"Cheng F.","year":"2012","unstructured":"Cheng F.; Li W.; Zhou Y.; Shen J.; Wu Z.; Liu G.; Lee P.W.; Tang Y.; admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 2012,52(11),3099-3105","journal-title":"J Chem Inf Model"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1386207322666190722162100","volume":"15","author":"Jadhav B.S.","year":"2019","unstructured":"Jadhav B.S.; Yamgar R.S.; Kenny R.S.; Mali S.N.; Chaudhari H.K.; Mandewale M.C.; Synthesis, In-Silico and biological studies of thiazolyl-2h-chromen-2-one derivatives as potent antitubercular agents. Curr Comput Aided Drug Des 2019,15,1","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.1002\/slct.201901775","volume":"4","author":"Kshatriya R.","year":"2019","unstructured":"Kshatriya R.; Kambale D.; Mali S.N.; Jejurkar V.P.; Lokhande P.; Chaudhari H.K.; Saha S.S.; Br\u00f8nsted Acid Catalyzed Domino Synthesis of Functionalized 4H\u2010Chromens and Their ADMET, Molecular Docking and Antibacterial Studies. ChemistrySelect 2019,4,7943-7948","journal-title":"ChemistrySelect"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/175838","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/175838\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/175838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T14:59:54Z","timestamp":1623855594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/175838\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409915666191018120611","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}